机译:替莫唑胺治疗多形性胶质母细胞瘤患者的严重持续性胆汁淤积性肝炎:案例研究和FDA不良事件报告系统的数据审查
Clinical Pharmacology and Toxicology, Charite Universitatsmedizin Berlin, Berlin, Germany;
Clinical Pharmacology and Toxicology, Charite Universitatsmedizin Berlin, Berlin, Germany;
Clinical Pharmacology and Toxicology, Charite Universitatsmedizin Berlin, Berlin, Germany;
Department of Surgery, Maria-Heimsuchung Caritas Klinik Pankow, Berlin,Germany;
Department of Gastroenterology, Vivantes Klinikum Friedrichshain, Berlin, Germany;
Department of Pathology, Vivantes Klinikum Neukolln, Berlin, Germany;
Clinical Pharmacology and Toxicology, Charite Universitatsmedizin Berlin, Berlin, Germany;
Clinical Pharmacology and Toxicology, Charite Universitatsmedizin Berlin, Berlin, Germany Department of Clinical Epidemiology, Bremen Institute for Prevention Research and Social Medicine, Bremen, Germany Bremen Institute for Prevention Research and Social Medicine, University of Bremen,Achterstr. 30, 28359 Bremen, Germany;
cholestasis; glioblastoma multiforme; hepatotoxicity; temozolomide;
机译:替莫唑胺导致的严重胆汁淤积性肝炎:请注意药物的不良作用。病例报告及文献复习
机译:由于替代唑粒子严重的胆汁淤积性肝炎:牢记的不良药物效果。案例报告和文学审查
机译:使用FDA不良事件报告系统和在线患者评论评估与抗流感神经氨酸酶抑制剂相关的不良事件
机译:关于开放医学数据中的知识发现,以阿仑膦酸(Fosamax)FDA药品不良事件报告系统为例
机译:寻求FDA不良事件报告系统(FAERS)和社交媒体之间的相关性:二级数据分析
机译:替莫唑胺治疗多形性胶质母细胞瘤患者的严重持续性胆汁淤积性肝炎:案例研究和FDA不良事件报告系统的数据审查
机译:替莫唑胺导致的严重胆汁淤积性肝炎:请牢记药物不良作用。病例报告和文献复习